By Kate Baggaley
NATIONAL HARBOR, Md.—Prescription digital therapeutics (PDTs) have excellent safety profiles and offer a nonpharmacologic route to improve outcomes for chronic conditions. However, ensuring that providers, patients and payors are on the same page for using PDTs is vital for success, according to a presentation at the Academy of Managed Care Pharmacy (AMCP) Nexus 2022 meeting.
OCTOBER 14, 2022